Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,253-9,264 of 23,847
Behavioral study icon
TerminatedNCT01733680

Amiloride Hydrochloride as an Effective Treatment for ADHD

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Syracuse
ADHDBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
State University of New York - Upstate Medical University
Condition
ADHD
Behavioral study icon
CompletedNCT00343928

Amino Acids, Serotonin, and Body Weight Regulation

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Eating disordersBehavioralFrom 18 Years to 40 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Eating disorders
Drug study icon
CompletedISRCTN68824876

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including London
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Irvine
SchizophreniaOtherFrom 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT03834766

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

Multiple locations, including Bradenton
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Tris Pharma, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.